Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cerebrovascular Diseases Extra|January 10, 2014
Postpartum four-vessel cervical artery dissectionBruno Barroso, Stéphanie DemaslesMultiple Sclerosis and Related Disorders|January 21, 2017
No evidence of disease activity (NEDA) in MS should include CSF biology - Towards a 'Disease-Free Status Score'Mickael Bonnan, Raluca Marasescu, Stéphanie Demasles, et al.Journal of Neuroimmunology|July 23, 2015
Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - a model of chronic CNS inflammation?Mickael Bonnan, Bruno Barroso, Stéphanie Demasles, et al.Multiple Sclerosis and Related Disorders|July 22, 2015
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatmentBruno Barroso, Marie Miquel, Raluca Marasescu, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 25, 2014
Middle cerebral artery dissection: diagnostic and prognostic value of transcranial color-coded sonographyBruno Barroso, Stéphanie Demasles, Eric Bertandeau, et al.Current Drug Targets|October 31, 2014
Intrathecal rituximab therapy in multiple sclerosis: review of evidence supporting the need for future trialsMickael Bonnan, Sylvie Ferrari, Eric Bertandeau, et al.Annals of Clinical and Translational Neurology|May 16, 2018
Estimation of intrathecal IgG synthesis: simulation of the risk of underestimationMickael Bonnan, Mariana Gianoli-Guillerme, Henri Courtade, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 30, 2020
Focal cortical atrophy following transient meningeal enhancement in a progressive multiple sclerosisMickael Bonnan, Paul Money, Pauline Desblache, et al.Presse Medicale (Paris, France : 1983)|February 27, 2007
[Headaches and acute hemiplegia of nonvascular origin: two cases]Bruno Barroso, Eric Bertandeau, Alexandre Dakar, et al.Multiple Sclerosis International|March 25, 2021
No Early Effect of Intrathecal Rituximab in Progressive Multiple Sclerosis (EFFRITE Clinical Trial)Mickael Bonnan, Sylvie Ferrari, Henri Courtade, et al.Pageof 2